中國人壽及平安人壽擬調整新備案保險產品預定利率最高值
據《證券時報》報道,中國保險業協會公布當前普通型人身保險產品預定利率研究值為1.99%,中國人壽及平安人壽等保險公司隨後發布關於人身保險產品預定利率等信息的公告,決定調整新備案保險產品的預定利率最高值。
其中,普通型保險產品預定利率最高值為2%,分紅型保險產品預定利率最高值為1.75%,萬能型保險產品最低保證利率最高值為1%。
據悉,兩大保險公司將於8月31日凌晨零時起不再接受超過該預定利率最高值的保險產品投保申請。(ta/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.